Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

835.77 +22.44 (+2.76%)
Streaming Delayed Price Updated: 1:40 PM EST, Dec 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,495,695
Open 828.10
Bid (Size) 835.53 (1)
Ask (Size) 835.99 (1)
Prev. Close 813.33
Today's Range 820.50 - 846.46
52wk Range 561.65 - 972.53
Shares Outstanding N/A
Dividend Yield 0.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Of The Day: Where Will The Eli Lilly Rally End?
Shares of Eli Lilly (LLY) are approaching a price level that had previously been a peak. There is a good chance they hit resistance at it. 
Via Benzinga

Performance

YTD
+41.13%
+41.13%
1 Month
+3.68%
+3.68%
3 Month
-12.62%
-12.62%
6 Month
+0.38%
+0.38%
1 Year
+42.70%
+42.70%

More News

Read More
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Via Benzinga
Eli Lilly Stock Hits 3-Week High, Boosts Retail Mood On Zepbound’s Edge Over Wegovy In Weight-Loss Trial Showdown
Via Stocktwits
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?
Via Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Via Benzinga
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
Eli Lilly's Zepbound Beats Novo Nordisk's Wegovy In Head-To-Head Weight-Loss Trial
Via Investor's Business Daily
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
Via The Motley Fool
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Via Benzinga
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Via Benzinga
Topics ETFs
Eli Lilly Gap
Via Talk Markets
Topics Stocks / Equities
It’s Been A Tough Month For Healthcare Stocks
Via Talk Markets
Topics ETFs Stocks / Equities
Macy's Multimillion-Dollar Error
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
Via Benzinga
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Via Benzinga
Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Again in 2025
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
Via The Motley Fool
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Via Benzinga
Does Billionaire Israel Englander Know Something Wall Street Doesn't? The Billionaire Investor Just Sold 8.1 Million Shares of Walmart Stock.
Via The Motley Fool
Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review
Via Investor's Business Daily
Topics Government
Exposures Political
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.